Literature DB >> 25167370

Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax.

Brad E Sleebs1, Michelle Gazdik, Matthew T O'Neill, Pravin Rajasekaran, Sash Lopaticki, Kurt Lackovic, Kym Lowes, Brian J Smith, Alan F Cowman, Justin A Boddey.   

Abstract

Following erythrocyte invasion, malaria parasites export a catalogue of remodeling proteins into the infected cell that enable parasite development in the human host. Export is dependent on the activity of the aspartyl protease, plasmepsin V (PMV), which cleaves proteins within the Plasmodium export element (PEXEL; RxL↓xE/Q/D) in the parasite's endoplasmic reticulum. Here, we generated transition state mimetics of the native PEXEL substrate that potently inhibit PMV isolated from Plasmodium falciparum and Plasmodium vivax. Through optimization, we identified that the activity of the mimetics was completely dependent on the presence of P1 Leu and P3 Arg. Treatment of P. falciparum-infected erythrocytes with a set of optimized mimetics impaired PEXEL processing and killed the parasites. The striking effect of the compounds provides a clearer understanding of the accessibility of the PMV active site and reaffirms the enzyme as an attractive target for the design of future antimalarials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25167370     DOI: 10.1021/jm500797g

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

Review 2.  Plasmodium species: master renovators of their host cells.

Authors:  Tania F de Koning-Ward; Matthew W A Dixon; Leann Tilley; Paul R Gilson
Journal:  Nat Rev Microbiol       Date:  2016-07-04       Impact factor: 60.633

3.  Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.

Authors:  Marvin J Meyers; Elizabeth J Anderson; Sarah A McNitt; Thomas M Krenning; Megh Singh; Jing Xu; Wentian Zeng; Limei Qin; Wanwan Xu; Siting Zhao; Li Qin; Christopher S Eickhoff; Jonathan Oliva; Mary A Campbell; Stacy D Arnett; Michael J Prinsen; David W Griggs; Peter G Ruminski; Daniel E Goldberg; Ke Ding; Xiaorong Liu; Zhengchao Tu; Micky D Tortorella; Francis M Sverdrup; Xiaoping Chen
Journal:  Bioorg Med Chem       Date:  2015-03-04       Impact factor: 3.641

4.  Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.

Authors:  Anthony N Hodder; Brad E Sleebs; Peter E Czabotar; Michelle Gazdik; Yibin Xu; Matthew T O'Neill; Sash Lopaticki; Thomas Nebl; Tony Triglia; Brian J Smith; Kym Lowes; Justin A Boddey; Alan F Cowman
Journal:  Nat Struct Mol Biol       Date:  2015-07-27       Impact factor: 15.369

Review 5.  Plasmodium falciparum Secretome in Erythrocyte and Beyond.

Authors:  Rani Soni; Drista Sharma; Tarun K Bhatt
Journal:  Front Microbiol       Date:  2016-02-19       Impact factor: 5.640

6.  Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.

Authors:  Peng Liu; Arthur H Robbins; Melissa R Marzahn; Scott H McClung; Charles A Yowell; Stanley M Stevens; John B Dame; Ben M Dunn
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

7.  A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.

Authors:  Paco Pino; Reto Caldelari; Budhaditya Mukherjee; Juha Vahokoski; Natacha Klages; Bohumil Maco; Christine R Collins; Michael J Blackman; Inari Kursula; Volker Heussler; Mathieu Brochet; Dominique Soldati-Favre
Journal:  Science       Date:  2017-10-27       Impact factor: 47.728

Review 8.  Protease Inhibition-An Established Strategy to Combat Infectious Diseases.

Authors:  Daniel Sojka; Pavla Šnebergerová; Luïse Robbertse
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

9.  Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.

Authors:  Luca Gambini; Luca Rizzi; Alessandro Pedretti; Orazio Taglialatela-Scafati; Mario Carucci; Andrea Pancotti; Corinna Galli; Martin Read; Emanuele Giurisato; Sergio Romeo; Ilaria Russo
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

10.  An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell.

Authors:  Michael J Coffey; Brad E Sleebs; Alessandro D Uboldi; Alexandra Garnham; Magdalena Franco; Nicole D Marino; Michael W Panas; David Jp Ferguson; Marta Enciso; Matthew T O'Neill; Sash Lopaticki; Rebecca J Stewart; Grant Dewson; Gordon K Smyth; Brian J Smith; Seth L Masters; John C Boothroyd; Justin A Boddey; Christopher J Tonkin
Journal:  Elife       Date:  2015-11-18       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.